Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-18-021896

Chief Financial Officer acquired 59 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Payne Fletcher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-03-26 Exercise or conversion : show line 1 in the form +59 $4.63 $273 59 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-03-26 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −59 $4.63 2027-07-11 59 74,941 D
Loading xslF345X03/doc4.xml…